You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
Design, development and optimisation of irinotecan human serum albumin nanoparticles
- In: Poster Presentation
- At: Stockholm (Sweden) (2017)
- Type: Poster
- Poster code: P-C-027-Tuesday
- By: SINGH, Kamalinder K (University of Central Lancashire, School of Pharmacy and Biomedical Sciences, Preston, United Kingdom)
- Co-author(s): Neetika Taneja: CU Shah College of Pharmacy, SNDT Women's University, Mumbai, India
Kamalinder K Singh: School of Pharmacy and Biomedical Sciences, University of Central Lancashire, Preston, United Kingdom;CU Shah College of Pharmacy, SNDT Women's University, Mumbai, India - Abstract:
Backgrounds
Human serum albumin(HSA) is emerging as a potential protein carrier for several drugs because of its advantages including non-immunogenicity, biodegradability and non-toxic nature. Irinotecan(Iro) is first line treatment of metastatic colorectal cancer.
Aims
The aim of present research was to prepare and optimize irinotecan loaded..
The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026